Cetera Investment Advisers
PFE icon

Cetera Investment Advisers’s Pfizer PFE Stock Holding History

Cetera Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90.2M Buy
3,213,627
+65,634
+2% +$1.75M 0.1% 203
2025
Q4 		$78.4M Buy
3,147,993
+188,643
+6% +$4.76M 0.09% 218
2025
Q3 		$75.4M Buy
2,959,350
+431,310
+17% +$10.6M 0.09% 214
2025
Q2 		$61.3M Buy
2,528,040
+192,889
+8% +$4.5M 0.1% 188
2025
Q1 		$59.2M Buy
2,335,151
+313,587
+16% +$8.21M 0.11% 182
2024
Q4 		$53.6M Sell
2,021,564
-40,924
-2% -$1.11M 0.11% 182
2024
Q3 		$59.7M Sell
2,062,488
-48,043
-2% -$1.4M 0.13% 156
2024
Q2 		$59.1M Sell
2,110,531
-91,555
-4% -$2.52M 0.14% 143
2024
Q1 		$61.1M Buy
2,202,086
+1,409,527
+178% +$39.1M 0.14% 135
2023
Q4 		$22.8M Sell
792,559
-84,426
-10% -$2.55M 0.19% 105
2023
Q3 		$29.1M Buy
876,985
+39,210
+5% +$1.39M 0.25% 73
2023
Q2 		$30.7M Buy
837,775
+15,291
+2% +$595K 0.26% 66
2023
Q1 		$33.6M Buy
822,484
+33,882
+4% +$1.46M 0.29% 57
2022
Q4 		$40.4M Buy
788,602
+156,576
+25% +$7.51M 0.37% 45
2022
Q3 		$27.7M Sell
632,026
-148,543
-19% -$7.22M 0.55% 26
2022
Q2 		$40.9M Buy
780,569
+1,670
+0.2% +$85.1K 0.65% 17
2022
Q1 		$40.3M Buy
778,899
+29,396
+4% +$1.53M 0.58% 22
2021
Q4 		$44.3M Buy
749,503
+7,359
+1% +$365K 0.63% 20
2021
Q3 		$31.9M Buy
742,144
+23,998
+3% +$1.06M 0.51% 30
2021
Q2 		$28.1M Buy
718,146
+44,425
+7% +$1.73M 0.45% 34
2021
Q1 		$24.4M Buy
673,721
+24,805
+4% +$881K 0.48% 34
2020
Q4 		$23.9M Buy
648,916
+538,038
+485% +$19.7M 0.47% 34
2020
Q3 		$3.86M Buy
110,878
+6,000
+6% +$210K 0.32% 78
2020
Q2 		$3.25M Buy
104,878
+27,782
+36% +$944K 0.3% 87
2020
Q1 		$2.39M Buy
77,096
+2,359
+3% +$80.4K 0.29% 91
2019
Q4 		$2.79M Buy
74,737
+3,151
+4% +$112K 0.28% 97
2019
Q3 		$2.45M Buy
71,586
+4,284
+6% +$156K 0.3% 91
2019
Q2 		$2.76M Buy
67,302
+2,021
+3% +$80.3K 0.36% 75
2019
Q1 		$2.62M Buy
65,281
+13,730
+27% +$550K 0.37% 75
2018
Q4 		$2.13M Sell
51,551
-1,553
-3% -$64.5K 0.35% 82
2018
Q3 		$2.21M Buy
53,104
+2,705
+5% +$104K 0.32% 84
2018
Q2 		$1.74M Buy
50,399
+2,509
+5% +$85.7K 0.31% 85
2018
Q1 		$1.62M Sell
47,890
-2,522
-5% -$86.7K 0.3% 90
2017
Q4 		$1.73M Sell
50,412
-491
-1% -$16.7K 0.32% 88
2017
Q3 		$1.73M Sell
50,903
-2,156
-4% -$69.3K 0.38% 69
2017
Q2 		$1.69M Buy
53,059
+14,001
+36% +$442K 0.41% 62
2017
Q1 		$1.26M Buy
39,058
+3,666
+10% +$116K 0.35% 82
2016
Q4 		$1.08M Buy
35,392
+6,519
+23% +$199K 0.36% 82
2016
Q3 		$930K Sell
28,873
-20,569
-42% -$688K 0.4% 73
2016
Q2 		$1.65M Buy
49,442
+3,434
+7% +$110K 0.65% 39
2016
Q1 		$1.29M Buy
46,008
+1,955
+4% +$55.8K 0.56% 49
2015
Q4 		$1.35M Buy
+44,053
New +$1.39M 0.62% 44

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cetera Investment Advisers's PFE Position: Q1 2026 in Review

Cetera Investment Advisers increased its Pfizer (PFE) stake by 2.1% in Q1 2026, buying an estimated $1.75M and bringing the position to 3,213,627 shares worth $90.2M. The position accounts for 0.1% of the portfolio, ranked #203.

Cetera Investment Advisers first reported a position in PFE in Q4 2015 and has held it in 42 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cetera Investment Advisers held 3,213,627 shares of Pfizer worth $90.2M as of Q1 2026.
  • Cetera Investment Advisers bought 65,634 Pfizer shares in Q1 2026, an estimated $1.75M.
  • Pfizer made up 0.1% of Cetera Investment Advisers's portfolio in Q1 2026, its #203 holding.
  • Cetera Investment Advisers first reported a position in Pfizer in Q4 2015 and has held it in 42 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.